News

The New Zealand government signed a deal on Monday to buy 1.5 million COVID-19 vaccines from Pfizer Inc and Germany’s BioNTech, with delivery potentially as early as the first quarter of 2021. The government did not disclose financial terms of...

The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life science and healthcare R&D, launched its new Innovation Seed Fund to finance early stage concepts in biopharma and healthcare. It aims to fund...

High Purity New England (HPNE), a leading supplier of biopharma equipment and process systems for the Biopharma industry announces its new line of Defined Tubing Routing (DTR), a flexible tubing support system targeted for single-use biopharmaceutical manufacturing. This modular...

COVID-19 Vaccine: In a Phase 1 trial of 191 healthy participants aged between 18 and 59, vaccination with the group's experimental shot showed no severe adverse reactions, its COVID-19 Vaccine: In a Phase 1 trial of 191 healthy participants...

The second of two GMP manufacturing sites for the UK’s specialist vaccines manufacturing equipment has been approved by the Medicines & Healthcare products Regulatory Agency (MHRA). Announced by the Vaccines Manufacturing and Innovation Centre (VMIC), the new site means there...

Phase-2 trials of Zydus Cadila's indigenous vaccine ZyCoV-D is moving in the right direction and the data will be available by the end of November and the vaccine is likely to be available by March 2021, said Pankaj R...

iBio, Inc., a biotech innovator and biologics contract manufacturing organization, announced that it has entered into a Master Services Agreement (“MSA”) with Boston-based Safi Biosolutions, Inc. (“Safi”) to evaluate iBio’s FastPharming® System for the expression of key proteins to...